Goldman Sachs is ditching its consumer banking distractions to double down on investment banking and trading, where it reigns ...

B. Riley Wealth Advisors cut its NVIDIA stake by 9.4%, selling nearly 106,000 shares in the fourth quarter. Despite the trim, ...

JPMorgan’s Chief Operating Officer, Jennifer Piepszak, made headlines by selling over 6,000 shares worth roughly $1.6 million ...

Coca-Cola is drawing investor attention, but the stock’s recent return of -1.4% has fizzed below the S&P 500’s gain. Despite ...

Wells Fargo is flexing its post-scandal muscles, diving into direct lending and targeting midsize firms and leveraged buyouts ...

Broadcom is on a winning streak, with shares climbing for seven straight sessions and inching toward record highs. The stock ...

Apple’s rough 2025 ride includes a 17% stock drop, trade war whiplash, and AI disappointments, but JP Morgan sees a silver ...

Warren Buffett, the master of stealth moves, is quietly buying shares of a mystery company using a confidential SEC filing.

TD Cowen has lowered Eli Lilly’s price target from $1,050 to $960, but maintained a Buy rating, citing solid long-term ...

Adobe received a fresh wave of optimism as RBC Capital reaffirmed its “Outperform” rating and a $480 price target. This ...

UnitedHealth is trying to calm investor nerves with a memo full of optimism and disclaimers. CEO Stephen Hemsley, freshly ...

AbbVie inched up 0.17% to $187.66, bucking the broader market’s downward trend. While the S&P 500 dipped 0.53%, AbbVie ...